Clinical trial · Observational
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
NCT02355340CI-TRIAL-00079500completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research study is evaluating bone mineral density in childhood cancer survivors who have a history of bone fracture.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bone Mineral Density | — | UNRESOLVED | — |
| Childhood Cancer Survivors | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dual energy x-ray absorptiometry (DXA) | Other | — | UNRESOLVED |
| Peripheral quantitative computed tomography (pQCT) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- DXA and pQCT Scan
- description
- * Dual energy x-ray absorptiometry (DXA): Assessment of bone mineral density * Peripheral quantitative computed tomography (pQCT): Assessment of bone mineral density
- interventionNames
- Other: Dual energy x-ray absorptiometry (DXA)
- Other: Peripheral quantitative computed tomography (pQCT)
Primary outcomes (2)
- measure
- Total body BMD (total body less head) and lumbar spine BMD
- timeFrame
- Participants to undergo a single baseline assessment on day 1; to be measured at ≥ 2 years since completion of cancer-directed therapy
- description
- DXA assessment (z-score)
- measure
- Volumetric BMD of distal radius
- timeFrame
- Participants to undergo a single baseline assessment on day 1; to be measured at ≥ 2 years since completion of cancer-directed therapy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 8 Years
- Maximum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * History of childhood cancer * Age ≥ 8 years and \< 20 years at time of enrollment * ≥ 2 years since completion of cancer-directed therapy for first cancer * Received chemotherapy for treatment of childhood cancer * History of bone fracture after the conclusion of chemotherapy\* * Not currently receiving cancer-directed therapy * Signed written informed consent (by parent if patient is \< 18 years of age, or by patient, if he or she is ≥18 years of age) * Patient assent for those ≥10 years of age and \< 18 years of age for whom a parent provides informed consent (\*History of bone fracture will be based on patient/parent report of fracture occurrence and will be confirmed in review of the medical record whenever feasible.) Exclusion Criteria: * Current treatment with bisphosphonates (as of time of enrollment) * Current treatment with the anticonvulsant depakote (at time of enrollment) * Currently pregnant
References
Publications (0)
Data not yet available
No reference posted for this study.